T-wave alternans as an arrhythmic risk stratifier: State of the art

Current Cardiology Reports

Volumn 15, Issue 9, 2013, Pages

  Merchant, Faisal M ^a   Sayadi, Omid ^b   Moazzami, Kasra ^b   Puppala, Dheeraj ^b   Armoundas, Antonis A ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Arrhythmia prevention; Arrhythmia risk stratification; Repolarization alternans; Sudden cardiac death; T wave alternans

Indexed keywords

ELECTROCARDIOGRAPHY; HEART ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; METHODOLOGY; PATHOPHYSIOLOGY; REVIEW; RISK ASSESSMENT; SUDDEN CARDIAC DEATH; ARRHYTHMIAS, CARDIAC; DEATH, SUDDEN, CARDIAC; PROCEDURES; TACHYCARDIA, VENTRICULAR;

ARRHYTHMIAS, CARDIAC; DEATH, SUDDEN, CARDIAC; ELECTROCARDIOGRAPHY; HUMANS; RISK ASSESSMENT; TACHYCARDIA, VENTRICULAR;

EID: 84884511193     PISSN: 15233782     EISSN: 15343170     Source Type: Journal    
DOI: 10.1007/s11886-013-0398-7     Document Type: Article

References (91)

1. Hering HE. Das Wesen des Herzalternans. Munchen Med Wchenshr. 1908;4:1417-21.
2. Ritzenberg AL, Adam DR, Cohen RJ. Period multiplying-evidence for nonlinear behavior of the canine heart. Nature. 1984;307:159-61. (Pubitemid 14132899)
3. Smith JM, Clancy EA, Valeri CR, Ruskin JN, Cohen RJ. Electrical alternans and cardiac electrical instability. Circulation. 1988;77:110-21. (Pubitemid 18031007)
4. Rosenbaum DS, Jackson LE, Smith JM, Garan H, Ruskin JN, Cohen RJ. Electrical alternans and vulnerability to ventricular arrhythmias. N Engl J Med. 1994;330:235-41. (Pubitemid 24034135)
5. Goldhaber JI, Xie LH, Duong T, Motter C, Khuu K, Weiss JN. Action potential duration restitution and alternans in rabbit ventricular myocytes: the key role of intracellular calcium cycling. Circ Res. 2005;96:459-66. (Pubitemid 40354540)
6. Diaz ME, Eisner DA, O'Neill SC. Depressed ryanodine receptor activity increases variability and duration of the systolic Ca2+ transient in rat ventricular myocytes. Circ Res. 2002;91:585-93.
7. Chudin E, Goldhaber J, Garfinkel A, Weiss J, Kogan B. Intracellular Ca(2+) dynamics and the stability of ventricular tachycardia. Biophys J. 1999;77:2930-41.
8. Jordan PN, Christini DJ. Action potential morphology influences intracellular calcium handling stability and the occurrence of alternans. Biophys J. 2006;90:672-80.
9. Kockskamper J, Zima AV, Blatter LA. Modulation of sarcoplasmic reticulum Ca2+ release by glycolysis in cat atrial myocytes. J Physiol. 2005;564(Pt 3):697-714. (Pubitemid 40704138)
10. Hüser J, Wang YG, Sheehan KA, Cifuentes F, Lipsius SL, Blatter LA. Functional coupling between glycolysis and excitation-contraction coupling underlies alternans in cat heart cells. J Physiol. 2000;524(Pt 3):795-806. (Pubitemid 30303626)
11. Pastore JM, Girouard SD, Laurita KR, Akar FG, Rosenbaum DS. Mechanism linking T-wave alternans to the genesis of cardiac fibrillation. Circulation. 1999;99:1385-94. (Pubitemid 29129926)
12. Pastore JM, Rosenbaum DS. Role of structural barriers in the mechanism of alternans-induced reentry. Circ Res. 2000;87:1157-63.
13. Laurita KR, Pastore JM, Rosenbaum DS. How restitution, repolarization, and alternans form arrhythmogenic substrates: insights from high-resolution optical mapping. In: Zipes DP, Jalife J, editors. Cardiac Electrophysiology: From Cell to Bedside. 2nd ed. Philadelphia, PA: W.B. Saunders; 1999. p. 239-48.
14. Fox JJ, McHarg JL, Gilmour Jr RF. Ionic mechanism of electrical alternans. Am J Physiol Heart Circ Physiol. 2002;282:H516-30.
15. Kameyama M, Hirayama Y, Saitoh H, Maruyama M, Atarashi H, Takano T. Possible contribution of the sarcoplasmic reticulum Ca(2+) pump function to electrical and mechanical alternans. J Electrocardiol. 2003;36:125-35. (Pubitemid 36628843)
16. Kihara Y, Morgan JP. Abnormal Cai2+ handling is the primary cause of mechanical alternans: study in ferret ventricular muscles. Am J Physiol. 1991;261(6 Pt 2):H1746-55.
17. Lab MJ, Lee JA. Changes in intracellular calcium during mechanical alternans in isolated ferret ventricular muscle. Circ Res. 1990;66:585-95. (Pubitemid 20086900)
18. Spear JF, Moore EN. A comparison of alternation in myocardial action potentials and contractility. Am J Physiol. 1971;220:1708-16.
19. Mahajan A, Sato D, Shiferaw Y, Baher A, Xie LH, Peralta R, et al. Modifying L-type calcium current kinetics: consequences for cardiac excitation and arrhythmia dynamics. Biophys J. 2008;94:411-23.
20. Hua F, Johns DC, Gilmour Jr RF. Suppression of electrical alternans by overexpression of HERG in canine ventricular myocytes. Am J Physiol Heart Circ Physiol. 2004;286:H2342-51. (Pubitemid 38685251)
21. Allen DG, Orchard CH. Myocardial contractile function during ischemia and hypoxia. Circ Res. 1987;60:153-68. (Pubitemid 17078830)
22. Armoundas AA. Mechanism of abnormal sarcoplasmic reticulum calcium release in canine left-ventricular myocytes results in cellular alternans. IEEE Trans Biomed Eng. 2009;56:220-8.
23. Weiss JN, Karma A, Shiferaw Y, Chen PS, Garfinkel A, Qu Z. From pulsus to pulseless: the saga of cardiac alternans. Circ Res. 2006;98:1244-53. (Pubitemid 43948079)
24. Narayan SM, Bayer JD, Lalani G, Trayanova NA. Action potential dynamics explain arrhythmic vulnerability in human heart failure: a clinical and modeling study implicating abnormal calcium handling. J Am Coll Cardiol. 2008;52:1782-92.
25. Pruvot EJ, Katra RP, Rosenbaum DS, Laurita KR. Role of calcium cycling vs restitution in the mechanism of repolarization alternans. Circ Res. 2004;94:1083-10. (Pubitemid 38579703)
26. Merchant FM, Armoundas AA. Role of substrate and triggers in the genesis of cardiac alternans, from the myocyte to the whole heart: implications for therapy. Circulation. 2012;125:539-49.
27. Choi BR, Salama G. Simultaneous maps of optical action potentials and calcium transients in guinea-pig hearts: mechanisms underlying concordant alternans. J Physiol. 2000;529(Pt 1):171-88.
28. Laurita KR, Girouard SD, Akar FG, Rosenbaum DS. Modulated dispersion explains changes in arrhythmia vulnerability during premature stimulation of the heart. Circulation. 1998;98:2774-80. (Pubitemid 28564015)
29. Laurita KR, Rosenbaum DS. Implications of ion channel diversity to ventricular repolarization and arrhythmogenesis: insights from high resolution optical mapping. Can J Cardiol. 1997;13:1069-76. (Pubitemid 28004548)
30. Lee HC, Mohabir R, Smith N, Franz MR, Clusin WT. Effect of ischemia on calcium-dependent fluorescence transients in rabbit hearts containing indo 1. Correlation with monophasic action potentials and contraction. Circulation. 1988;78:1047-59.
31. Qian YW, Clusin WT, Lin SF, Han J, Sung RJ. Spatial heterogeneity of calcium transient alternans during the early phase of myocardial ischemia in the blood-perfused rabbit heart. Circulation. 2001;104:2082-7. (Pubitemid 33027050)
32. Wu Y, Clusin WT. Calcium transient alternans in blood-perfused ischemic hearts: observations with fluorescent indicator fura red. Am J Physiol. 1997;273(5 Pt 2):H2161-9.
33. Armoundas AA. Mechanism of abnormal sarcoplasmic reticulum calcium release in canine left ventricular myocytes results in cellular alternans. IEEE Trans Biomed Eng. 2009:In press.
34. Kuo CS, Amlie JP, Munakata K, Reddy CP, Surawicz B. Dispersion of monophasic action potential durations and activation times during atrial pacing, ventricular pacing, and ventricular premature stimulation in canine ventricles. Cardiovasc Res. 1983;17:152-61. (Pubitemid 13113951)
35. Chinushi M, Restivo M, Caref EB, El-Sherif N. Electrophysiological basis of arrhythmogenicity of QT/T alternans in the long-QT syndrome: tridimensional analysis of the kinetics of cardiac repolarization. Circ Res. 1998;83:614-28. (Pubitemid 28427745)
36. Chinushi M, Kozhevnikov D, Caref EB, Restivo M, El-Sherif N. Mechanism of discordant T wave alternans in the in vivo heart. J Cardiovasc Electrophysiol. 2003;14:632-8. (Pubitemid 36724389)
37. Wilson LD, Jeyaraj D, Wan X, Hoeker GS, Said TH, Gittinger M, et al. Heart failure enhances susceptibility to arrhythmogenic cardiac alternans. Hear Rhythm. 2009;6:251-9.
38. del Monte F, Lebeche D, Guerrero JL, Tsuji T, Doye AA, Gwathmey JK, et al. Abrogation of ventricular arrhythmias in a model of ischemia and reperfusion by targeting myocardial calcium cycling. Proc Natl Acad Sci U S A. 2004;101:5622-7. (Pubitemid 38481206)
39. •• Cutler MJ, Wan X, Plummer BN, Liu H, Deschenes I, Laurita KR, et al. Targeted sarcoplasmic reticulum Ca2+ ATPase 2a gene delivery to restore electrical stability in the failing heart. Circulation. 2012;126:2095-104. This paper highlights the close relationship between contractile dysfunction and arrhythmogenesis in pre-clinical models.
40. Takei M, Sasaki Y, Yonezawa T, Lakhe M, Aruga M, Kiyosawa K. The autonomic control of the transmural dispersion of ventricular repolarization in anesthetized dogs. J Cardiovasc Electrophysiol. 1999;10:981-9. (Pubitemid 29297717)
41. MERIT-HF. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet. 1999;353:2001-7. (Pubitemid 29271744)
42. Poole-Wilson PA, Swedberg K, Cleland JG, Di Lenarda A, Hanrath P, Komajda M, et al. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. Lancet. 2003;362:7-13. (Pubitemid 36835815)
43. Ng GA, Brack KE, Patel VH, Coote JH. Autonomic modulation of electrical restitution, alternans and ventricular fibrillation initiation in the isolated heart. Cardiovasc Res. 2007;73:750-60. (Pubitemid 46227349)
44. Euler DE, Guo H, Olshansky B. Sympathetic influences on electrical and mechanical alternans in the canine heart. Cardiovasc Res. 1996;32:854-60. (Pubitemid 26342650)
45. Corr PB, Yamada KA, Witkowski FX. Mechanisms controlling cardiac autonomic function and their relationships to arrhythmogenesis. In: Fozzard HA, Haber E, Jennings RB, et al., editors. The Heart and Cardiovascular System. New York: Raven Press; 1986. p. 1343-404.
46. Rubart M, Zipes DP. Mechanisms of sudden cardiac death. J Clin Invest. 2005;115:2305-15. (Pubitemid 41266189)
47. Schwartz PJ, Zipes DP. Autonomic modulation of cardiac arrhythmias. In: Zipes DP, Jalife J, eds. Cardiac Electrophysiology: From Cell to Bedside (3rd ed.): W. B. Saunders. 2000:300-14.
48. Janse MJ, Schwartz PJ, Wilms-Schopman F, Peters RJ, Durrer D. Effects of unilateral stellate ganglion stimulation and ablation on electrophysiologic changes induced by acute myocardial ischemia in dogs. Circulation. 1985;72:585-95. (Pubitemid 15242253)
49. Billman GE. A comprehensive review and analysis of 25 years of data from an in vivo canine model of sudden cardiac death: implications for future anti-arrhythmic drug development. Pharmacol Ther. 2006;111:808-35. (Pubitemid 44160523)
50. Armoundas AA, Hohnloser SH, Ikeda T, Cohen RJ. Can microvolt T-wave alternans testing reduce unnecessary defibrillator implantation? Nat Clin Pract Cardiovasc Med. 2005;2:522-8. (Pubitemid 41670343)
51. Gehi AK, Stein RH, Metz LD, Gomes JA. Microvolt T-wave alternans for the risk stratification of ventricular tachyarrhythmic events: a meta-analysis. J Am Coll Cardiol. 2005;46:75-82. (Pubitemid 40905133)
52. Fishman GI, Chugh SS, Dimarco JP, Albert CM, Anderson ME, Bonow RO, et al. Sudden cardiac death prediction and prevention: report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop. Circulation. 2010;122:2335-48.
53. Stecker EC, Vickers C, Waltz J, Socoteanu C, John BT, Mariani R, et al. Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction: 2-year findings from the Oregon Sudden Unexpected Death Study. J Am Coll Cardiol. 2006;47:1161-6.
54. Rautaharju PM, Surawicz B, Gettes LS, Bailey JJ, Childers R, Deal BJ, et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part IV: the ST segment, T and U waves, and the QT interval: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology. J Am Coll Cardiol. 2009;53:982-91.
55. Chow T, Kereiakes DJ, Onufer J, Woelfel A, Gursoy S, Peterson BJ, et al. Does microvolt T-wave alternans testing predict ventricular tachyarrhythmias in patients with ischemic cardiomyopathy and prophylactic defibrillators? The MASTER (Microvolt T Wave Alternans Testing for Risk Stratification of Post-Myocardial Infarction Patients) trial. J Am Coll Cardiol. 2008;52:1607-15.
56. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-83. (Pubitemid 34984635)
57. Gold MR, Ip JH, Costantini O, Poole JE, McNulty S, Mark DB, et al. Role of microvolt T-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction: primary results from the T-wave alternans sudden cardiac death in heart failure trial substudy. Circulation. 2008;118:2022-8.
58. • Hohnloser SH, Ikeda T, Cohen RJ. Evidence regarding clinical use of microvolt T-wave alternans. Hear Rhythm. 2009;6(3):S36-44. This paper elucidates the confounding role that including ICD therapies as an endpoint in risk stratification trials may have on defining the utility of T-wave alternans testing.
59. Ellenbogen KA, Levine JH, Berger RD, Daubert JP, Winters SL, Greenstein E, et al. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy? Circulation. 2006;113:776-82.
60. Germano JJ, Reynolds M, Essebag V, Josephson ME. Frequency and causes of implantable cardioverter-defibrillator therapies: is device therapy proarrhythmic? Am J Cardiol. 2006;97:1255-61.
61. •• Merchant FM, Ikeda T, Pedretti RF, Salerno-Uriarte JA, Chow T, Chan PS, et al. Clinical utility of microvolt T-wave alternans testing in identifying patients at high or low risk of sudden cardiac death. Hear Rhythm. 2012;9:1256-64. This paper highlights the robust role of T-wave alternans testing in clinical risk stratification among patients without ICDs.
62. Chow T, Kereiakes DJ, Bartone C, Booth T, Schloss EJ, Waller T, et al. Microvolt T-wave alternans identifies patients with ischemic cardiomyopathy who benefit from implantable cardioverter-defibrillator therapy. J Am Coll Cardiol. 2007;49:50-8. (Pubitemid 46026898)
63. • Weiss EH, Merchant FM, d'Avila A, Foley L, Reddy VY, Singh JP, et al. A novel lead configuration for optimal spatio-temporal detection of intracardiac repolarization alternans. Circ Arrhythm Electrophysiol. 2011:407-17. This paper describes a novel intra-cardiac system to optimize detection of repolarization alternans. Optimized detection is an important step in the ability to deliver upstream anti-arrhythmic therapies.
64. Costantini O, Hohnloser SH, Kirk MM, Lerman BB, Baker II JH, Sethuraman B, et al. The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention. J Am Coll Cardiol. 2009;53:471-9.
65. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225-37. (Pubitemid 40110811)
66. Bloomfield DM, Steinman RC, Namerow PB, Parides M, Davidenko J, Kaufman ES, et al. Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum. Circulation. 2004;110:1885-9. (Pubitemid 39331896)
67. Reynolds MR, Cohen DJ, Kugelmass AD, Brown PP, Becker ER, Culler SD, et al. The frequency and incremental cost of major complications among medicare beneficiaries receiving implantable cardioverter-defibrillators. J Am Coll Cardiol. 2006;47:2493-7. (Pubitemid 43866387)
68. Zareba W, Moss AJ, le Cessie S, Hall WJ. T wave alternans in idiopathic long QT syndrome. J Am Coll Cardiol. 1994;23:1541-6. (Pubitemid 24182116)
69. Nearing BD, Huang AH, Verrier RL. Dynamic tracking of cardiac vulnerability by complex demodulation of the T wave. Science. 1991;252:437-40. (Pubitemid 21916981)
70. Zareba W, Moss AJ, le Cessie S, Locati EH, Robinson JL, Hall WJ, et al. Risk of cardiac events in family members of patients with long QT syndrome. J Am Coll Cardiol. 1995;26:1685-91.
71. Verrier RL, Nearing BD, Ghanem RN, Olson RE, Garberich RF, Katsiyiannis WT, et al. Elevated T-Wave Alternans Predicts Nonsustained Ventricular Tachycardia in Association with Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction (STEMI) Patients. J Cardiovasc Electrophysiol. 2012;24:658-63.
72. Takasugi N, Kubota T, Nishigaki K, Verrier RL, Kawasaki M, Takasugi M, et al. Continuous T-wave alternans monitoring to predict impending life-threatening cardiac arrhythmias during emergent coronary reperfusion therapy in patients with acute coronary syndrome. Europace. 2012;13:708-15.
73. Nieminen T, Nanbu DY, Datti IP, Vaz GR, Tavares CA, Pegler JR, et al. Antifibrillatory effect of ranolazine during severe coronary stenosis in the intact porcine model. Hear Rhythm. 2011;8:608-14.
74. Tachibana H, Kubota I, Yamaki M, Watanabe T, Tomoike H. Discordant S-T alternans contributes to formation of reentry: a possible mechanism of reperfusion arrhythmia. Am J Physiol. 1998;275(1 Pt 2):H116-21.
75. Shimizu W, Antzelevitch C. Cellular and ionic basis for T-wave alternans under long-QT conditions. Circulation. 1999;99:1499-507. (Pubitemid 29140918)
76. Fox JJ, Riccio ML, Hua F, Bodenschatz E, Gilmour Jr RF. Spatiotemporal transition to conduction block in canine ventricle. Circ Res. 2002;90:289-96. (Pubitemid 34633930)
77. Qu Z, Garfinkel A, Chen PS, Weiss JN. Mechanisms of discordant alternans and induction of reentry in simulated cardiac tissue. Circulation. 2000;102:1664-70.
78. Watanabe MA, Fenton FH, Evans SJ, Hastings HM, Karma A. Mechanisms for discordant alternans. J Cardiovasc Electrophysiol. 2001;12:196-206. (Pubitemid 32171511)
79. Shusterman V, Goldberg A, London B. Upsurge in T-wave alternans and nonalternating repolarization instability precedes spontaneous initiation of ventricular tachyarrhythmias in humans. Circulation. 2006;113:2880-7. (Pubitemid 44297228)
80. Nearing BD, Wellenius GA, Mittleman MA, Josephson ME, Burger AJ, Verrier RL. Crescendo in depolarization and repolarization heterogeneity heralds development of ventricular tachycardia in hospitalized patients with decompensated heart failure. Circ Arrhythm Electrophysiol. 2012;5:84-90.
81. Kim JW, Pak HN, Park JH, Nam GB, Kim SK, Lee HS, et al. Defibrillator electrogram T wave alternans as a predictor of spontaneous ventricular tachyarrhythmias in defibrillator recipients. Circ J. 2009;73:55-62.
82. Armoundas AA, Albert CM, Cohen RJ, Mela T. Utility of implantable cardioverter defibrillator electrograms to estimate repolarization alternans preceding a tachyarrhythmic event. J Cardiovasc Electrophysiol. 2004;15:594-7. (Pubitemid 38621913)
83. Swerdlow CD, Zhou X, Voroshilovsky O, Abeyratne A, Gillberg J. High amplitude T-wave alternans precedes spontaneous ventricular tachycardia or fibrillation in ICD electrograms. Hear Rhythm. 2008;5:670-6.
84. •• Swerdlow C, Chow T, Das M, Gillis AM, Zhou X, Abeyratne A, et al. Intracardiac electrogram T-wave alternans/variability increases before spontaneous ventricular tachyarrhythmias in implantable cardioverter- defibrillator patients: a prospective, multi-center study. Circulation. 2011;123:1052-60. This paper demonstrates the feasibility of intra-cardiac detection of repolarization alternans in predicting ICD therapy and opens the door to delivery of upstream, abortive anti-arrhythmic therapies.
85. Paz O, Zhou X, Gillberg J, Tseng HJ, Gang E, Swerdlow C. Detection of T-wave alternans using an implantable cardioverter-defibrillator. Hear Rhythm. 2006;3:791-7. (Pubitemid 43960543)
86. Brunckhorst CB, Shemer I, Mika Y, Ben-Haim SA, Burkhoff D. Cardiac contractility modulation by nonexcitatory currents: studies in isolated cardiac muscle. Eur J Heart Fail. 2006;8:7-15. (Pubitemid 43012095)
87. Winter J, Brack KE, Ng GA. The acute inotropic effects of cardiac contractility modulation (CCM) are associated with action potential duration shortening and mediated by beta1-adrenoceptor signalling. J Mol Cell Cardiol. 2011;51:252-62.
88. Armoundas AA, Weiss EH, Sayadi O, Laferriere S, Sajja N, Mela T, et al. A novel pacing method to suppress repolarization alternans in vivo: implications for arrhythmia prevention. Heart Rhythm. 2013;10:564-72.
89. Merchant FM, Dec GW, Singh JP. Implantable sensors for heart failure. Circ Arrhythm Electrophysiol. 2010;3:657-67.
90. Narayan SM, Bode F, Karasik PL, Franz MR. Alternans of atrial action potentials during atrial flutter as a precursor to atrial fibrillation. Circulation. 2002;106:1968-73. (Pubitemid 35176303)
91. Narayan SM, Franz MR, Clopton P, Pruvot EJ, Krummen DE. Repolarization alternans reveals vulnerability to human atrial fibrillation. Circulation. 2011;123:2922-30.